Prospera Financial Services Inc Celldex Therapeutics, Inc. Transaction History

Prospera Financial Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$32.76 - $42.56 $254,021 - $330,010	7,754 New	7,754 $286,000
Q1 2024 Aug 13, 2024	SELL	$35.22 - $51.88 $68,045 - $100,232	-1,932 Reduced 24.92%	5,822 $244,000
Q2 2022 Aug 08, 2022	SELL	$20.5 - $37.33 $53,751 - $97,879	-2,622 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$27.64 - $39.32 $72,472 - $103,097	2,622 New	2,622 $89,000
Q4 2020 Feb 12, 2021	SELL	$14.99 - $22.75 $56,032 - $85,039	-3,738 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$9.65 - $15.19 $36,071 - $56,780	3,738 New	3,738 $55,000

199

65.9M

1.68M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.15B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.